Phuturdex › Diseases › Adverse drug reaction
Drugs in development · updated 30 October 2026
Adverse drug reaction: drugs in development
As of 30 October 2026 there are 8 active clinical trials (recruiting or ongoing, phases I–III) on 11 drugs for adverse drug reaction. 4 are experimental, that is not yet approved in the United States.
Summary updated every week · data as of 30 October 2026. In Phuturdex you get the full detail of every drug and an email when an alert is published on the ones you follow.
Sign in free →Experimental drugs
Not yet approved by the US FDA for any indication.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| MelatoninSlenyto®, Circadin® | III | 1 | NCT05084196 |
| LY3537021 | II | 1 | NCT07169851 |
| SerplulimabHLX10, Hetronifly® | I | 2 | NCT06716619 |
| ADCX-020 | I | 1 | NCT07238075 |
Sorted by most advanced phase and number of active trials.
Approved drugs in new trials
Approved by the US FDA for at least one indication, not necessarily this disease, and now in active trials on it.
| Drug | Most advanced phase | Active trials | Reference trial |
|---|---|---|---|
| DuloxetineDrizalma Sprinkle®, Cymbalta® | III | 1 | NCT06407401 |
| EtomidateAmidate® | III | 1 | NCT05358535 |
| FurosemideLasix Onyu®, Furoscix® | III | 1 | NCT06407401 |
| InfliximabZymfentra®, Avsola® | II | 1 | NCT04305145 |
| MethylprednisoloneMethylprednisolon, Methylprenisolone | II | 1 | NCT04305145 |
| PrednisonePredinisone, Cortancyl | II | 1 | NCT04305145 |
| CyclophosphamideCyclophosphamid, Cytoxan | I | 1 | NCT06302062 |
Sorted by most advanced phase and number of active trials.
All 11 drugs, with the details
In Phuturdex every drug has all its trials, sponsors and countries, FDA and EMA approvals, orphan designations and safety alerts. Free until 31 March 2027.
Open in Phuturdex →Specific forms
- Cardiotoxicity 21 drugs
- Breast neoplasm 593 drugs
- Ototoxicity 3 drugs
- Drug Hypersensitivity 17 drugs
- Diffuse large B-cell lymphoma 177 drugs
- Lymphoma 252 drugs
- Drug Hypersensitivity Syndrome 4 drugs
- Hodgkin lymphoma 93 drugs
- Heart failure 104 drugs
- Cardiomyopathies 23 drugs
- Ovarian neoplasm 411 drugs
- Cognitive dysfunction 94 drugs
Broader categories
- Neoplasm 671 drugs
- Skin disease 34 drugs
- Skin and connective tissue diseases 3 drugs
- Renal Insufficiency 51 drugs
- Kidney disease 38 drugs
- Urologic Diseases 16 drugs
Source: Phuturdex analysis of ClinicalTrials.gov data (U.S. National Library of Medicine), updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III, with at least one identified drug; phase and sites refer to the trials on this disease. Disease name: Wikidata; NLM MeSH term: D064420 “Drug-Related Side Effects and Adverse Reactions”.